Alex Zhavoronkov, Ph.D., is applying recent advances in artificial intelligence to aging and cancer research. He is the chief science officer of the bio-gerontology research foundation, a UK-based registered charity, supporting the aging research and the CEO of Insilico Medicine headquartered at Johns Hopkins University in Baltimore. The company is focusing on applying deep learning and advanced signaling pathway activation analysis to biomarker discovery, drug discovery and drug repurposing for aging. He is also the director of the international aging research portfolio knowledge management project and head of the Regenerative Medicine Laboratory at the federal clinical research center. Since 2011, he has authored over 50 publications in peer-reviewed journals and published several books including ‘The Ageless Generation: How advances in biomedicine will transform the global economy’. Dr. Zhavoronkov helped organize many biotechnology conferences in the US. Currently he is co-organizing the annual Practical Applications of Aging Research Forum at the Basel Life Science Week, one of Europe"s largest industry events in drug discovery. He holds two bachelor degrees from Queen’s University, masters in biotechnology from Johns Hopkins University, and a Ph.D. in biophysics from Moscow State University.